Common asthma treatment reduces need for hospitalisation in COVID-19 patients.
Early treatment with a medication commonly used to treat asthma appears to significantly reduce the need for urgent care and hospitalisation in people with COVID-19, researchers at the University of Oxford have found. The STOIC study found that inhaled budesonide given to patients with COVID-19 within seven days of the onset of symptoms also reduced …
Common asthma treatment reduces need for hospitalisation in COVID-19 patients. Read More »